Search

everythinglearnresearchcommunity

for

Search:↓

CGF and i-PRF are more effective and safer than PRP for treating female pattern hair loss.

Hair loss from conditions like LPP and FFA can potentially be reversed with the right treatment.

Platelet-rich plasma (PRP) may help treat hair loss in patients with frontal fibrosing alopecia who don't respond to other treatments.

Botanical extracts can help treat hair loss in people with certain genetic conditions.

The critique highlights an error in a review about hair loss treatment, stressing the need for accurate information and caution due to poor evidence quality.

Laser hair reduction can sometimes cause a rare skin condition called Fox-Fordyce disease.

The new anti-aging ingredient improves skin hydration, elasticity, and reduces wrinkles.

Cepharanthine shows promise as a COVID-19 treatment.

Inducing ferroptosis in hepatic stellate cells is crucial for treating liver fibrosis.

Being allergic to linalool, a common fragrance ingredient, might contribute to developing frontal fibrosing alopecia.

FGF5 spliceosomes inhibit rabbit hair growth by affecting gene expression.

Scientists turned mouse skin cells into hair-inducing cells using chemicals, which could help treat hair loss.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

TrichoScan offers a painless way to analyze and manage hair loss.

The new skin patch with human matrix and antibiotic improves wound healing.

Ac-GFFY-IGF peptide is a promising, safe, and effective treatment for hair loss, better than current options.

The new drug carriers show promise for better targeting and treating ovarian cancer.

Pig blood plasma can be used to promote human hair growth and is a good alternative to the commonly used serum additive.

A new method improves protein extraction from hair, helping identify potential biomarkers for fetal growth issues.

Nanofat shows promise for facial rejuvenation and treating skin issues but needs more research for long-term safety.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

Frontal fibrosing alopecia is linked to four genetic areas, especially the HLA-B*07:02 allele.

Cosmeceuticals effectively treat skin issues but need better regulation and safety measures.

Finasteride in lipid carriers improved hair growth in rats.

Eflornithine improved symptoms in Bachmann–Bupp Syndrome patients.

Increasing the levels of a protein called FGF9 can promote hair growth, but humans may not respond the same way due to a lack of certain cells.